drugset / Trial / NCT03896945
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786, as compared with placebo, for the treatment of negative symptoms of schizophrenia.
Timeline
- Start
- 2019-02-15
- Primary completion
- 2023-05-23
- Completion
- 2023-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deudextromethorphan | Unknown | — | Oral |
| Subject | Quinidine | Small molecule | — | Oral |